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Abstract
In the last decade, phylogenetic approach is recurrent in molecular evolutionary analysis. On May 12th, 
2019, about 2.296.213 papers are found, but typing “phylogeny” or “epidemiology AND phylogeny” 
only 199.804 and 20.133 are retrieved, respectively. Molecular epidemiology in infectious diseases is 
widely used to define the source of infection as so as the ancestral relationships of individuals sampled 
from a population. Coalescent theory and phylogeographic analysis have had scientific application in 
several, recent pandemic events, and nosocomial outbreaks. Hepatitis viruses and Immunodeficiency 
Virus (HIV) have been largely studied. Phylogenetic analysis has been recently applied on 
Polyomaviruses so as in the more recent outbreaks due to different Arboviruses type as Zika and 
Chikungunya viruses discovering the source of infection and the geographic spread. 
Data on sequences isolated by the microorganism are essential to apply the phylogenetic tools and 
research in the field of infectious disease phylodinamics is growing up. There is the need to apply 
molecular phylogenetic and evolutionary methods in areas out of infectious diseases, as translational 
genomics and personalized medicine. Lastly the application of these tools in vaccine strategy so as in 
antibiotic and antiviral researchers are encouraged.  
Key word: Evolution; Epidemiology; Research and analysis methods
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Introduction
Typing in PubMed “Epidemiology” at the date of May 12th, 2019, about 2,296,213 papers can be found, 
but typing “Phylogeny” only 199,804 are retrieved. Curiously typing “epidemiology AND phylogeny” 
20,133 articles appear (Figure 1). This is conceivable thinking to the origin of epidemiology and 
phylogeny. Epidemiological concept was born at the time of Hippocrates considered to be the first 
epidemiologist (Figure 2A). Hippocrates was a Greek physician, he wrote a book called “On AIRS 
WATERS, PLACES” were he described epidemics. On the other hand, phylogeny probably has as 
father Charles Darwin (Figure 2B) and his principles in a theory of evolution due to natural selection, 
principles and theory divide with the thinking of Russel Wallace. The first phylogenetic tree is due to 
Walter Fitch and Emanuel Margoliash, in 1967 “Construction of phylogenetic trees. A method based on 
mutation distances as estimated from cytochrome c sequences is of general applicability “(1). 
Phylogenetics is a branch of molecular epidemiology that infers knowledge about taxonomy so as the 
evolution of microorganisms (2). It is a powerful tool, widely used in the study of rapidly evolving RNA 
viruses as well as recently in bacteria applying phylogenetic analysis in nosocomial infection (3-5).  In 
the last years, a number of new methods that infer phylogenetic trees have been introduced. These 
methods are based on Bayesian theory introducing the statistical phylogenetic with two important 
concepts: the molecular clock hypothesis and the coalescent theory (6-8). Genetic distances and 
phylogenetic trees (coupled with a correct epidemiological design i.e., cross sectional studies), inferred 
via different sequence evolutionary models, are normally used to assign the genotype (9). In addition, 
phylogeny has been widely used to define circulating recombinant forms (CRFs), to discover mosaics 
and complex form of the virus (10-13). Coalescent theory and the molecular clock hypothesis are 
instead used to study the ancestral relationships of individuals sampled from a population (i.e. 
longitudinal studies) which can be inferred from a gene genealogy (phylogenetic tree) (10, 13-16). The 
link between epidemiological design and phylogeny inference can be seen as a hypothetical cycle 
starting with the specific evolutionary hypothesis and going on through data generation, data analysis 
and test hypothesis (Figure 3). Depending on the scientific question raised and on the availability of 
molecular epidemiological data, normally the first step analysis is based on maximum likelihood criteria 
(12), followed by phylodinamic criteria, molecular clock hypothesis and Bayesian techniques that are 
normally applied (12). Molecular epidemiological investigation has a historical and scientific 
application in Global infection diseases. In several relevant and recent pandemic events, as severe acute 
respiratory syndrome SARS (17-20), avian influenza A subtype H5N1 virus (21-23), H1N1 influenza A 
virus (24-28), Zaire Ebola virus (EBOV) (29-32) and lastly Zika virus (ZIKV), phylodinamic analysis 
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has been fruitful applied (33-36). All these epidemic events have been resolved, first applying the 
principles of classical epidemiology, quarantine and isolation, and then using phylodinamic principles 
representing drivers to the solution of the origin and the diffusion of the epidemics. 
Hepatitis
The population dynamics and the circulation of hepatitis viruses has been investigated to better 
understand the origin and the migrations of these viruses by phylogenetic and phylodinamic approaches 
(Figure 4).
Phylogenesis and phylodinamic of Hepatitis A Virus (HAV) 
Molecular epidemiology and phylogenetic analysis of HAV isolates have been proved crucial for 
understanding the demographic, social and environmental factors responsible for the current worldwide 
epidemiological patterns.
HAV is non-enveloped, single-st anded RNA virus belonging to the Picornaviridae family, genus 
Hepatovirus.
Molecular epidemiological investigation of HAV outbreaks is usually done using a short genomic 
region, like the VP1-P2A junction for the greatest simplicity in obtaining reliable results during an 
epidemic.
Several foodborne HAV outbreaks have been described and HAV infected food handlers have been 
frequently identified as a source of HAV outbreaks (37-40). The food-borne outbreak of hepatitis A 
occurred in the U.S.A. in 2005 was associated with the consumption of contaminated row oysters and 
phylogenetic analysis identified the same VP1-P2B sequence in the oysters and in oyster consumers (41, 
42); a more detailed analysis of whole-genome sequences showed that HAV strains involved in the 
outbreak were genetically heterogeneous but closely related (43).
Two important outbreaks related to the consumption of imported raw or undercooked mussels have 
occurred in 1996‐1997 and in 2002 in Campania and Apulia regions of Southern Italy, respectively (44), 
with most of the HAV isolates clustering as genotype Ia by phylogenetic analysis (45). Between 
September and November 2003, 1,023 cases of hepatitis A cases had been registered in in Tennessee, 
North Carolina, Georgia and Pennsylvania (U.S.A.) (46, 47), associated to the consumption of green 
onions grown in Mexico. Sequence analysis of the VP1-P2B region identified 3 HAV variants tightly 
clustered in phylogenetic tree (46, 47). However, the evaluation of the HAV whole-genome sequences 
showed that a much greater number of strains were involved (43).
An outbreak of acute hepatitis A due to the consumption of semi-dried tomatoes occurred in England in 
2012 (48). The phylogenetic analysis identified multiple HAV strains of subtype IB and attributed the 
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genetic variability to viral evolution at the local source of the production rather than to substitutions in 
each infected individual (43). 
Genetic analyses of HAV outbreaks has demonstrated the occurrence of person-to-person transmission 
in large families, day care centers or schools, commonly due to contacts with infected asymptomatic 
children (49) acting as reservoirs of HAV infection. In accordance with the above, Pelletier et al. 
reported a limited outbreak of hepatitis A in a large family in the U.S.A., in which the cases were 
primary or secondary contacts of an HAV infected foreign adoptee (50). 
Molecular analysis is crucial for the identification of the source of HAV infection, especially when 
infected cases do not declare risk factors (51, 52), especially in countries with low HAV endemicity, 
where outbreaks are usually associated with a single HAV strain (53). Conversely, when outbreaks 
occur in highly endemic geographic areas an exposure to several HAV strains should be expected (54-
60).
In recent years, numerous outbreaks of acute hepatitis A have occurred in men who have sex with men 
(MSM) in Europe (61, 62), in the U.S.A. (63) and in Japan (64), with specific HAV IIIA strains 
circulating among MSM communities identified by phylogenetic trees (65-68).
A large outbreak of hepatitis A has been identified in central Italy, with 523 cases identified between 
January 2016 and March 2017. This outbreak had an extremely high male to female ratio, suggesting 
that sexual practices between males were implicated in the transmission of this infection. In support of 
this hypothesis the Authors found that several cases were due to the HAV variant circulating in Europe 
in the same period among MSM (VRD_521_2016) (69). 
Monophyletic clusters of HAV IA variants have been also identified in MSM in Spain, Italy, U.S.A. (66, 
67, 70) and in previous HAV outbreaks occurred in MSM in several European countries. 
Outbreaks of acute hepatitis A in IDUs has been reported in North American and North European 
countries (71-73). In Norway, IIIA strains have been identified in IDUs with parenterally acquired HAV 
infection (74). Two samples clustered in sub-genotype IIIA, closely related to variants identified in 
outbreaks occurred in Norwegian and Swedish IDUs communities in the same period (75). 
The analysis of sequences based on sub-genomic regions is of practical use for epidemic investigation, 
but it does not allow a specific identification of the HAV strain. Instead, a more precise genetic 
resolution of the HAV strains can be achieved by the analysis of the whole genome sequences and intra-
host heterogeneity, which represent a great opportunity for phylogenetic analysis and deeper knowledge 
of HAV molecular evolution. 
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Phylogenesis and phylodinamic of Hepatitis B Virus (HBV)
Phylogenetic studies may help to understand the origin, evolution and geographic dispersion of HBV 
due to its high genetic heterogeneity. 
The main difficulty in reconstructing the HBV phylodinamic is the lack of a consensus in the estimation 
of the rate of evolution of the virus that affects also the tMRCA estimates and the timescales of HBV 
evolution (76). Studies based on external (“fossil”) calibration points (77, 78, 79) describe HBV as a 
slowly evolving virus, whereas those based on internal calibration approaches (such as the use of 
heterochronous sequences) indicate that it is a highly variable virus evolving at a rate comparable with 
that of retroviruses (80). A recent study, re-estimating the viral evolutionary rate in known transmission 
chains, observed different rates at intra and inter host levels suggesting a reduced rate in transmission 
event with in general lower evolutionary rates on transmitted lineages (80). 
1. Phylogenesis of genotype D
Several studies have reconstructed very different histories for the different HBV genotypes (81).
From the first studies, the original introduction of genotype D has been dated in the early 20th century 
(76, 82).
The phylogeographical reconstruction of the HBV genotype D history (83) indicates that it originated in 
India being the subgenotype D5 the first to diverge. A common ancestor of the remaining HBV-D 
subgenotypes left India in the first decade of the twentieth century and reached central Asia, where D1 
and D3 diverged. Subsequently, they spread to Europe and Mediterranean area by means of a 
Southwestern pathway (mainly followed by subgenotype D1), reaching North Africa and the 
Southeastern Mediterranean through the Middle East. A second north-western pathway (due to the 
spread of D2) that overflow in the eastern Europe and through the former Soviet Union and iron curtain 
countries reached the Mediterranean basin (Albania) (83).
The World Wars played a crucial role in the global spread of HBV-D from India to the rest of the world, 
but the further spread of the infection was probably sustained by unsafe use of injections in medical 
practice (84).
2. The phylogeny of genotype A
Genotype A originated in Africa and penetrated in Europe in the XVI and XVII centuries following the 
Portuguese trades and ships and in Asia because of trade and travel between eastern Africa and southern 
Asia (85). 
Page 6 of 51
John Wiley & Sons
Journal of Medical Virology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
7
Several studies suggested a recent origin of HBV-A2 in Europe, between 1960s and 1980s through the 
sexual transmission, particularly men-having-sex-with-men (MSM) (76, 86) among who a single clonal 
strain has been isolated among high-risk subjects all over the world (87, 88). 
HBV-A1 most probably originated in Africa and the slave trade and colonization played a major role in 
its global dispersion (89). 
A recent phylogeographic study suggested that the origin of the currently circulating HBV-A 
subgenotypes originated in West Africa more than 1,000 years ago and was exported to Asia in the 17th 
century through the Portuguese or Arab trades and to Latin America in the following century through 
the transatlantic slave trade. On the contrary, HBV-A2 subgenotype originated more recently, in the 20th 
century and spread in Western countries between 1970s and 1990s, mainly among subjects at high risk 
of infection (90).
3. The phylogeny of genotype E
The observation that all isolates of genotype E are included in a single monophyletic group together and 
are absent among Afro-Americans (91). On the contrary, the phylodinamic studies, reconstructing the 
timescale of the HBV-E evolution suggested its spread in west Africa between 200 and 60 years ago 
(92). These observations support the view that the explosive spread of HBV-E in Africa must have been 
due to a new and highly efficient route of transmission, probably the unsafe use of needles during 
numerous mass-vaccination campaigns, in the 1920s and 1960s (92, 93). A recent study confirmed the 
origin of HBV-E to half XIX century, and showed that it was introduced in Madagascar before 1970s 
but remained confined until recently, when an exponential growth was observed as far as the first 
decade of 2000s, when the skyline plot showed a plateau (94). 
4. The phylogeny of genotypes F and H
The observation that genotypes F and H share a common ancestor and are evolutionarily distant from 
the Old World genotypes but closely related to an isolate obtained from a woolly monkey of the New 
World suggested a long history of evolution of these genotypes, possibly representing the result of a 
cross-species transfer (95). 
The phylogeography of HBV-F indicates the pre-Columbian origin of HBV-F and its expansion during 
the rapid increase in the Latin American population since the XVIII century (78).
A study of HBV-F in Colombia, demonstrated that HBV-F3 was probably the oldest F sub-genotype 
being the most related to genotype H (96). 
Other studies (97) have suggested a possible origin of the F and H genotypes going back to the initial 
human New World settlements around 13,000 years ago and a divergence time at least 10,000 years ago. 
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5. The phylogeny of genotypes B and C 
A recent study, using a “fossil” calibration approach have proposed that HBV genotype C as the oldest 
human genotype originating about 30.0 kya (98). This result seems to be confirmed by the detection of 
HBV nucleic acids in a Korean mummy of the 16th century which phylogenetically grouped with 
subgenotype C2 (99) suggesting a relatively low rate of HBV-C evolution. 
To date no phylogenetic studies were conducted on genotype G. Two new genotypes (I and J) have been 
recently proposed (100, 101); but they have been shown to be recombinant forms and their identification 
remained as far as mainly sporadic (102). 
Phylogenesis and phylodinamic of Hepatitis C Virus (HCV) 
About 3% of the world’s population are chronically infected with HCV, accounting for 150–180 million 
people worldwide, with about 3.5 million new chronic infections per year (103, 104).  It has ben also 
estimated that about 350,000 deaths per year and a quarter of cases of hepatocellular carcinoma (HCC) 
are attributable to HCV infection (105). 
Although a progressive decline in the incidence of HCV acute infection has been registered in Western 
countries, HCV chronic HCV infection remains a serious health problem (106, 107).
The phylogenetic analysis verifies how the viral strains are genetically correlated, if mutation is the only 
cause of viral differences. Regarding HCV, phylogenetic clustering has been used as a tool to identify 
the characteristics associated with a higher probability of HCV transmission. (108, 109). 
In Western countries, HCV-genotypes 1A, genotype 1B and genotype 3A have been widely spread 
through the transfusion of blood or its derivate before a reliable test to identify HCV infection had 
become available and through needle sharing between drug users (IDUs) (110). At present, these HCV 
genotypes affect most HCV patients in these geographic areas (111-113).
Both HCV genotypes and subtypes (114) are differently distributed around the world (115-117). HCV 
genotyping is achievable by phylogenetic methods. HCV- genotypes 1 and 3 are worldwide distributed, 
(118). Genotypes 1 and 2 are endemic in Western African countries (Burkina Faso, Ghana, Guinea 
Bissau, Republic of Benin and Nigeria) but sporadically found also in Italy (119-124), genotypes 1 and 
4 predominates in the Democratic Republic of Congo and Gabon and genotype 4 in Central and Middle 
East Africa so as in Turkey (120, 125-131).  HCV genotype 3 is endemic in Asia (39% of all infections), 
where also genotype 6 is widely distributed in the South-East regions (132). Genotype 5 is the most 
common HCV genotype in South Africa and in Belgium and genotype 7 has been detected only in 
Central African immigrants tested in Canada (133). 
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9
 Phylogenetic studies on HCV subtypes showed that genotype 3A strongly predominates in North 
America, Europe and Oceania, whereas it accounts for only half chronic infection in India, where other 
subtypes have been detected like genotype 3B in 20,3% of cases, genotype 3G in 6,8% and 3I in 3,6% 
(134, 135).
Among factor impairing the response to Direct Acting Antivirals (DAAs) is the presence of baseline 
Resistance-Associated Substitutions (RASs) as evidenced in case of DAA-naive patients with genotype 
3 infection showing RASs in the NS5A region (136). The relevance and the clinical impact of these 
strains strongly suggest further phylogenetic and epidemiological investigations.
Phylogenesis and phylodinamic of Hepatitis E virus (HEV)
Only limited works focused their attention in the phylogenetic studies of HEV genotypes, in particular 
those causing zoonotic infections (HEV-3 and -4). An early study performed from Purdy et al. (137) 
estimated a divergence time of the genotypes 1–4 ancestor between anthropotropic and enzootic 
genotypes about 536 to 1344 years ago and suggested a possible enzootic ancestor concomitantly with 
the split of human and swine variants.
By Skyline plot analysis, genotype 1a number of infection increased until 1970-1980 years followed by 
a plateau in the last twenty years, whereas genotypes 3 and 4 increased around 1940 to 1945 years and 
decreased around 1990. The hypothesis was that the observed increases could be related to World War 
II and the population movement from urban to more rural settings or, additionally, to more lax sanitation 
procedures.
HEV-3 is the best described genotype. It is classified in 10 subtypes (3a-j) with a strong geographic 
structure, which group into two main clades: one including subtypes 3abchij and the second including 
3efg (138). Based on phylodinamic and phylogeographic studies, the second clade (called B in the study 
of Zehender et al.) (139) consists of mainly European strains, while the first clade (A) includes a 
subclade of European isolates (3c) and a second subclade of mainly Asian and all the North American 
(grouping into subtype 3a) isolates. Dated trees suggested the origin of the HEV-3 in the XIX or XVIII 
century (139, 140), while the penetration of this virus in Asia dated the first decades of 1900s. The 
oldest clade resulted 3b, with an origin in 1920s including Japanese isolates (141) suggesting an 
introduction of this strain in Japan after the fall of the ban on meat consumption and the increase of pork 
importation mainly from Europe (139, 141). The phylodinamic analysis showed an exponential growth 
of the infection between 1950s until recently (2000s). A recent study published two complete genomes 
of genotype 3 isolated, one was classified as 3i, a subtype already detected in boars in Europe, but never 
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detected before in Italy either in animals or in humans, the second strain did not resulted classified in the 
subtypes defined to date (142). 
Genotype 4 has been described mainly in Asia and it is classified into nine subtypes (4a-i) but was 
recently isolated in a small epidemic in Rome (143) in five patients living in the same area without 
travel in endemic areas. Given the scarcity of available sequences of HEV-4, only a single study 
described the phylodinamic of this HEV genotype, which suggests that the most probable origin of this 
genotype is Japan in the first decade of 1900s. The virus then was exported to China and from there to 
India, Indonesia, Korea, Taiwan and, sporadically, also to Europe (144).
Phylogenetic and phylodinamic analysis contributed to knowledge deepening in the evolutionary 
reconstruction of HEV virus history and transmission dynamic.
Phylogenesis and phylodinamic of  Human Immuno deficiency Virus (HIV)
In the field of HIV-1 the phylogeny was primarily used to identify new genetic forms and trace the 
spread of HIV-1 subtypes. The combination with recombination analysis permitted the definition of an 
increasing number of CRFs (circulating recombinant forms), 98 published to date.
Tracing of genetic forms is important for epidemiological purposes but can also be of relevance in 
clinical settings, as it is well known that some biological properties differ among subtypes. The subtype 
variants can be affect antiviral drug resistance development (145-150), the genetic barrier to drug 
resistance development and/or disease progression (151-154). A recent paper from Abecasis et al. (155) 
studied the HIV epidemics in Europe and analyzed the circulation of HIV-1 non B subtypes. Authors 
concluded that it is clear that some non-B subtypes imported into Europe remained largely limited to 
migrant populations and risk groups analysis, where subtypes are clearly compartmentalized. The 
prevalence of subtype B was higher in the MSM risk group compared to heterosexuals that are more 
frequently infected with non-B subtypes. This evidence indicated highly stratified epidemics in different 
countries and risk groups suggesting the need of target preventive measures to specific populations. The 
work by Magiorkinis et al. (156) describes the global pattern of HIV-1 migration across the Western 
Hemisphere. On the contrary, of Gilbert et al that evidenced the role of the American continent and the 
Caribbean as “outwards” for the Western epidemic at the initial random migration event (157). 
Magiorkinis et al. evidenced a constant subsequent spread to the rest of the world. In the global context, 
this study defined the limited role of Europe in the spread of HIV Western epidemic, highlighting that 
the incoming infections spread mainly among regional populations.
Many recent studies have focused their attention on the study of migrants in different countries as they 
frequently are at increased risk of many diseases compared with native populations due to many factors 
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such as structural barriers and social inequalities. Determining when HIV-1 acquisition has occurred, 
pre migration or post migration, is crucial to design adequate HIV-1prevention programs, HIV-1 testing 
strategies and treatment services. Recently, some evidence supports that migrants acquire HIV-1 
infection post migration. In reference to the European situation, data from Alvarez-del Arco et al. (158) 
reported that 63% of HIV-positive migrants acquired infection after migrating into Europe. Also in this 
work, the proportion of post migration infection varies according to patient origin and risk categories 
with a highest percentage of HIV-1 diagnosis in subjects from Latin America and Caribbean (71%), in 
particular in MSM (79%). Similarly, Paraskevis et al. (159) found that the HIV-1 infections in migrants 
were more frequently acquired after the arrival in Greece and through contacts between migrants. 
Comparable results were reported from Pantazis et al. (160) that reported the post migration infection in 
half of studied subjects (55,3%). 
A number of published works evaluated at local level the circulation of HIV variants in many countries 
and in specific population such as MSM (161-163) and IDU (164-165). These papers highlighted the 
presence of multiple epidemic clusters, tried to reconstruct the date of HIV introduction in different 
areas and analyzed their dynamics at population level. Theses knowledge represents a substantial 
increase in our depth of knowledge on which interventions can be based.
Phylogenetic analysis is an important way to trace epidemiological relationship in cases with dubious or 
unknown links. In this context, phylogeny has been recurrently used as a forensic tool in HIV 
transmission investigations. Phylogeny permit to identify groups of genetic isolates that form genetically 
related clades with strains closely related. The application of phylogenetic methods was so extended in 
the context of HIV-specific criminal laws that precise rolls were defined (166, 167). Lemey et al. (168) 
applied phylogeny to a possible HIV- 1 transmission case, in which 6 females presumably became HIV 
infected after a sexual assault from an African suspect. The conclusions of this work highlighted that 
viral strains from the victims were more closely related to the virus carried by the suspect with respect to 
used controls, but did not exclude the possibility of the presence of an additional subject that could have 
infected both suspect and victims. In another case (169), the results of phylogenic analyses resulted to be 
more definitive permitting the liberation the foreign medical staff who was accused of transmitting the 
HIV strain to children attending Al-Fateh Hospital in Benghazi in Libya. The authors demonstrated that 
the HIV-1 and HCV strains related to young victims were already circulating and prevalent in this 
hospital and its environs before the arrival in March 1998 of suspects.
Considering the very rapid HIV evolution and the fact that molecular sequences taken at different points 
in time showed a statistically significant number of genetic differences; HIV-1 evolution was also 
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studied in the microcosm represented of viral sequences sampled longitudinally i.e. heterochronous 
sequences obtained from an infected host. The main results from these studies showed a correlation 
between the intra-host evolutionary rate disease progression, linear or inverse (170, 171). The founding 
of supported monophyletic clades including sequences isolated from a specific tissue supported the 
existence of diverse HIV-1 subpopulations infecting different body tissues (172, 173).
The comparison of HIV-1 intra-host genealogies from patients sampled under different conditions could 
help in understanding the viral reservoir dynamics, the most important knowledge for the HIV-1 vaccine 
design.
Phylogenetic and phylodinamic analysis contributed to consistent improvement in the evolutionary 
reconstruction of HIV virus history.
Phylogenesis and phylodinamic of Arboviruses
Phylogenetic and population genetic inference (phylodinamics) based on viral whole genome data can 
resolve putative outbreaks, investigate their aetiology, and provide spatiotemporal context during 
investigations (174).
Many of the important zoonotic arboviruses belong to the families Togaviridae (Chikungunya virus, 
CHIKV) and Flaviviridae (Zika Virus, ZIKV; Yellow Fever virus, YFV; Dengue virus, DENV) (175). 
The main vector able to spread zoonotic viruses are the mosquitoes, especially (Culex spp., Aedes spp., 
etc.). These may act as vectors for the same virus in different vertebrate hosts, depending on different 
geographical and ecological locations. 
Phylogenetic analyses can reveal a better picture of arboviral outbreak, as have been occurred in Brazil 
in CHIKV outbreak. Phylogenetic reconstruction suggests several separate introductions of the Asian 
genotype (ECSA) strain, in contrast to a unique introduction of the ECSA genotype followed by virus 
dissemination inside the country (176, 177) also in Dengue virus outbreaks (178). In CHIKV Italian 
outbreak in September 2017, phylodinamic analysis showed that the virus was in loco at least 3 months 
before the outbreak and in particular it probably originated in Pakistan and not India as the classical 
epidemiology supposed (179).
As well as in ZIKV outbreaks, phylogenetic inference showed how the outbreak in Brazil was closely 
related to the French Polynesia isolates that circulated in November 2013 (35, 180) and that all viruses 
sampled in the Americas, including those from Brazil, form a robust monophyletic cluster the Asian 
genotype. Meanwhile in United States, ZIKV outbreaks appeared to had multiples introductions linked 
to the Caribbean (181)
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The application of Bayesian statistical inference framework, can allow the reconstruction of the 
geographic history of the still ongoing and never reported before epidemic on the basis of the first 
isolates sampled at known times (182). It has been showed that CHIKV was imported to the Americas 
from Southeast Asia (183-187).
During CHIKV outbreak in 2005-2006, non-synonymous mutation (A226V) occurred both on La 
Reunion and in some Indian area (188). The phylogenetic analysis highlighted how the sporadic finding 
of A226V, that allowed a vector jump from Aedes aegypti to ae. albopictus, was possible probably due 
to the importation of mutated strains from Indian Ocean islands to the Indian subcontinent. Moreover, 
the analysis showed the likely eastward path from Africa to Indian Ocean Island to India, and from there 
to other South East Asian countries (188).
The phylogenetic analyses allowed to understand the epidemiology history and how the viruses spread 
in the infected countries and inside the country with the possibility to plan prevention strategies (181, 
189, 190)
Phylogeny of human polyomaviruses
Polyomaviruses belong the Polyomaviridae family that according to the International Committee on 
Taxonomy of Viruses (ICTV) includes four genera named alpha-, beta-, gamma- and delta-
polyomavirus that together include 83 species (https://talk.ictvonline.org/taxonomy). This taxonomic 
classification is based on the phylogenetic analysis of the Large T Antigen (LT Ag) coding sequences. 
Up to 2007, two human polyomaviruses were known: BKPyV and JCPyV both uncovered in 1971 and 
named after the initials of the patients where they were first isolated (191, 192). According to Jin et al., 
four serotypes of BKPyV exist based on the differences between amino acids 61-83 in the VP1 region. 
These four serotypes corresponded to the four subtypes characterized by sequencing or restriction 
fragment length polymorphisms (193, 194).
Subtype I has a worldwide distribution, subtype IV is present in Asia and part of Europe, and subtypes II 
and III are rarely detected. Phylogenetic analysis of full- length genomes revealed the presence of 
subgroups within subtypes I (Ia, Ib1, Ib2 and Ic) and IV (IV a1, IV a2, IVb1, IVb2, IVc1, IVc2) (195, 
196). 
JCPyV, the etiological agent of Progressive Multifocal Leukoencephalopathy (PML) usually observed 
in immunocompromised patients, especially HIV positive, is classified into a major VP1 serotype and at 
least seven major genotypes by phylogenetic analysis. These genotypes present a characteristic 
geographic distribution (197, 198) that allowed us to trace the human migrations from the African 
continent where human beings first appeared to the rest of the world. JCPyV type 1 predominates 
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between Europeans and European-Americans, types 2 and 7 are found in Asia, and types 3 and 6 in 
Africa. Genotype 4 found between European-Americans in USA is closely related to the genotype 1 
from which it differs of about 1% at DNA level (199). 
In 2007 the discovery of two new human polyomaviruses named KIPyV and WUPyV isolated from the 
respiratory secretions of patients affected by acute respiratory tract infection was reported (200, 201). At 
phylogenetic analysis analysis, these two viruses formed a new subclass of polyomaviruses. KIPyV was 
phylogenetically related to other primate polyomaviruses in the early region of the genome, but had a 
little homology, <30% amino acid identity, in the late region of the genome when compared to known 
polyomaviruses (200). Phylogenetic analysis clearly revealed that WUPyV was a novel virus closely 
related to KIPyV. In the early VP1region, WU/KI was most related to the primate polyomaviruses BK, 
SV40, JC, and baboon polyomavirus. On the other hand, analysis of the VP2 open reading frame 
showed that WUPyV was very much divergent from other polyomaviruses aside from KIPyV (201). In 
the following years, phylogenetic analysis of whole genome sequences evidenced three WUPyV 
genotypes and five subtypes: Ia, Ib, Ic, II, IIIa and IIIb. No association was noted between genotype and 
distinct clinical features (202). 
In 2008, a fifth novel human polyomavirus was discovered. This novel human polyomavirus was named 
Merkel cell polyomavirus (MCPyV) (203) belonging to the genus Alphapolyomavirus was described as 
causing agent of Merkel cell carcinoma a rare and aggressive skin cancer usually affecting the elderly 
and immunocompromised individuals (204). Neighbor-joining trees for putative MCPyV LT, sT, VP1, 
and VP2 proteins revealed that the four known human polyomaviruses BKPyV, JCPyV, KIPyV, and 
WUPyV clustered together in the SV40 subgroup, whereas MCPyV was most closely related to MuPyV 
subgroup viruses and African green monkey (AGM) lymphotropic polyomavirus (LPyV) (203).
Phylogenetic analysis, performed by the NJ method and using MCPyV complete genome sequences 
indicated the presence of two clades highly supported by high bootstrap values. These clades were 
provisionaly named by the authors as A for MCPyV strains isolated from individuals of Asian 
background and C for those strained isolated from patients of Caucasian background (205-207). Other 
authors have more recently confirmed the exsistence of an Asian genotype (208). These data suggest a 
geographic distribution of MCPyV genotypes similarly to BKPyV and JCPyV viruses (209). 
Following MCPyV discovery, two other human polyomaviruses were identified in the skin of healthy 
individuals named HPyV6 and HPyV7 (207). HPVy7 has been associated with a pruritic rash in two 
lung transplant recipients (210). HPyV6 has been linked to Kimura disease, a chronic inflammatory 
disorder with subcutaneous nodules that is endemic in East Asia (211). Phylogenetic analysis performed 
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on the LT gene sequences revealed the presence of two distinct clades. All the HPyV strains originated 
from the Japanese patients belonged to the Asian/Japanese clade indicating an Asian/Japanese genotype 
(252). 
The trichodysplasia spinulosa-associated polyomavirus (TSPyV) genome was amplified from in plucked 
facial spines of a heart transplant patient with trichodysplasia spinulosa (212). Phylogenetic analysis 
revealed a close relationship of TSPyV with the Bornean orangutan polyomavirus and, more distantly, 
the Merkel cell polyomavirus; the causative agent of Merkel Cell Carcinoma (MCC).
. Maximum likelihood phylogenetic tree analysis of the VP1, VP2 and LTAg proteins revealed that 
MWPyV was highly divergent from all known polyomaviruses. Based on VP2 and LTAg sequences, 
MWPyV clustered with the clade containing HPyV9, LPyV, HaPyV, MPyV, TSPyV, MCV, ChPyV and 
the orangutan polyomaviruses. These discordant phylogenetic relationships suggest that MWPyV is 
probably derived from an ancest al recombination event (213). Currently, MWPyV has not been 
associated to any specific human disease.
STLPyV was uncovered screening the fecal microbiota of a child living in Malawi (214). This novel 
polyomavirus is closely related to MWPyV but phylogenetic analysis revealed that MWPyV and 
STLPyV form distinct clades with high confidence. 
HPyV12 is novel human polyomavirus originally identified in a resected liver tissue by a generic PCR 
targeting the VP1 gene. Phylogenetic analysis showed that HPyV12 was not closely related to any 
known human or animal polyomavirus (215).
NJPyV-2013, is the last novel human polyomavirus identified in a young pancreatic transplant recipient 
with retinal blindness and vascular myopathy (216). Phylogenetic analysis performed on whole genome 
sequences, showed that NJPyV-2013 is most closely related to chimpanzee polyomavirus.  Phylogenetic 
and phylodinamic analysis contributed to a further improvement in the evolutionary reconstruction of 
Polyoma virus history causing human infections.
Role of phylogenetic analysis in vaccine strategies
One of the most effective ways to prevent infectious diseases is to use vaccines that stimulate a 
protective immune response upon subsequent contact with the pathogen.
An effective vaccination strategy is strictly connected to the knowledge of the microbial origin, spread 
and evolution, especially whenever a novel pathogen emerges, and predicting the course of evolution is 
one of the most challenging and important areas in infectious diseases (217). Availability of microbe 
species genome sequences and application of system biology to the field of vaccinology, have provided 
new ways for identification and evaluation of potential vaccine candidates. Phylogenetic analysis is one 
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of the best tools for studying the adaptive evolution of pathogens, and it is used to investigate outbreaks 
or endemic diseases and the history of the pandemics-including the pattern (when, where, how) of 
disease spreading throughout the world (218, 219). 
Despite the wide use of vaccines, vaccination failure is possible due to the emergence of variants that 
escape vaccination. Thus, it is pivotal to determine the genetic diversity between circulating field strains 
and the currently used vaccine strains. Indeed, the change of genetic material is one of the major 
mechanisms that pathogens use to escape the host immune response, and that leads to outbreaks of 
infectious disease (220). Vaccine development deals with the interplay of fitness, diversity, dynamics 
and virulence, which are the most important factors of viral evolution, and phylogenetic analysis is a key 
tool to evaluate all together these factors. 
Here, some examples in which phylogenetic analysis has improved design and development of vaccines 
have been provided. 
We consider first RNA viruses, like influenza and HIV, which pose grave risk to public health 
worldwide. These fast evolving viruses continuously adapt to the highly variable environments they 
live, by evading host immune responses and altering the severity of disease (221). Influenza viruses, that 
infects about one fifth of the worldwide human population each year, are characterized by a very rapid 
evolution, resulting from mutations or genetic re-assortment with other of influenza viruses, such as pig 
horses and birds (222). This is why there is a new vaccine each year (223). Since 90’s it was clearly 
shown by phylogeny that, strains with amino acid changes at hemagglutinin sites tended to become the 
dominant strain next year (224). This permanent evolution necessitates of vaccine composition updates, 
based on the selection of strains that antigenically match currently circulating influenza viruses (225). 
Thus, use of phylogenetic methods to influenza sequence data, has become an integral part of the yearly 
vaccine design cycle. To date, computational analysis-assisted vaccine design established for influenza, 
has not been equally successful for HIV. While every years, influenza strains diverge by about 1 to 2 
percent in the population (226), in comparison HIV strains, diverge about one percent per year within a 
single individual. Phylogenetic analysis showed that the genetic structure of the HIV epidemic tends to 
spread out from an ancestor in a radial fashion to generate high variation (227). The evolutionary 
dynamics of HIV strains involve multiple processes as high replication rates and recombination, 
selective pressure exerted by the host immune system and by drugs, and genetic drift (228). Thus far, 
designing a vaccine to cover all, or fraction of HIV diversity has appeared to be impossible (229). The 
high evolutionary rate of HIV makes the needed progress in virus vaccine strategies, which are a critical 
component for controlling the HIV epidemic. In this regard, new vaccine approaches are coming by use 
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of computational vaccine design. For example, to conceive computer-generated artificial proteins, that 
potentially may stimulate a broader immune response than natural HIV proteins, phylogenetics and 
computational techniques are used. Researchers make a “consensus” sequences, including the most 
common amino acid at each position from a broad number of sequences HIV’s variation, to create 
proteins that will serve as immunogens in vaccines. This methodology, that uses bioinformatics tools for 
vaccine development starting from genomic information of the pathogen, is called reverse vaccinology. 
However, until today, this approach has failed to deliver an effective, preventive HIV-1 vaccine (230).
Another rapidly evolving virus, which is a major public health problem, is Hepatitis B virus (HBV) 
(231). HBV infection is caused by a partially double-stranded reverse-transcribed DNA virus, 
with genetic variability related to high levels of virus production, and absence of 
viral polymerase proofreading activity during the reverse transcription step of the replication cycle. 
Because of genomic structure and unusual replication cycle, it is difficult to estimate exactly rate of 
virus evolution. HBV is more comparable to an RNA virus that use reverse transcriptase than a DNA 
virus, with a mutation rate (0,0005 substitutions per site per year) as compared with HIV (0,003 
substitutions per site per year). Phylogenetic analysis has revealed ten human genotypes of HBV, from 
A to J, with a sequence divergence larger than 8% (232). Pyogenesis of novel variants, generated by 
recombination events between different HBV genotypes, have documented their presence worldwide, 
confirming their potential for spreading in a wide range of human populations and developing their own 
epidemiology (233). For example, in low endemicity countries with high immigration rates, 
phylogenetic analyses provided essential information on the molecular epidemiology and population 
dynamics of HBV. Current HBV vaccines contain correctly folded HBsAg and neutralizing epitopes of 
the S antigen, induce rapid protection and overcome nonresponse to second-generation vaccines. 
However, recombination, evasion of host immunity, vaccine escape and resistance to drugs have been 
associated with evolutionary aspects of HBV genetic variability. Mutations of the determinant "a" in S 
antigen, generating variants that "escape" from vaccination, called escape mutants, and that induce 
infection also in subjects who have protective titers of anti-HBs, have been described (234). With an 
ever better vaccine formulation and vaccination coverage, eradication of HBV would be possible.
Varicella–zoster virus (VZV) is the only herpesvirus for which a vaccine has been developed. Human 
herpes viruses present low natural mutation rate, and stability of VZV genome is likely related in part to 
the small number of replication cycles during primary infection (235). To date, five major clades 
confirmed by full-genome sequencing have been established for VZV. It is thought that recombination 
to have played a crucial role in the evolution of VZV. Indeed, a point of phylogenetic interest for VZV, 
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is that vaccine in use for many years, may have significantly altered the natural epidemiology of wild-
type virus in the human populations (236). Although VZV wild-type recombinants have been rarely 
reported (237) recombination might occur presumably also between wild-type and vaccine strains. Thus, 
surveillance of VZV molecular epidemiology is indicated to detect changes in strain prevalence where 
VZV vaccine is in use.
Integration of mathematical evolutionary modeling with experimental data will produce important 
information on protein sequence and structure analysis to make a prevision on the effect that selective 
pressure could have on aminoacidic residue essential for vaccine development  or drugs activity (Figure 
5). play an increasingly important role in the development of new vaccines and the control of infectious 
disease.
Phylogenetic analysis of whole genome sequencing for viral nosocomial outbreak investigation.
During last years, the introduction of advanced molecular techniques and of bioinformatics analysis in 
the routine clinical practice has largely modified the diagnostic approach to infectious disease. By Next 
Generation Sequencing (NGS) technology, the whole genome sequencing (WGS) of pathogen 
microorganisms has been introduced improving the ability to identify and control epidemic outbreaks, 
thus preventing the spread of the pathogen and decreasing morbidity and mortality (240). Phylogenetic 
analysis applied to whole genome sequences has been used for the epidemiological surveillance of 
nosocomial infections as recently reported (3, 4, 241).
The application of WGS and phylogenetic analysis for nosocomial investigation has been used 
prevalently in case of hospital acquired infection caused by bacteria commonly isolated by simple 
culture of different biological samples (3,4, 241, 242) The use of this new technology in nosocomial 
viral infection has been more limited but some reports have been published. 
A first report on the use of metagenomics NGS for the investigation of a nosocomial outbreak by 
Parainfluenza Virus 3 was published by Greninger et al in 2016. By Bayesian phylogenetic analysis, 
these authors demonstrated that two strains causing HAI have the same sequence confirming the 
hypothesis of a possible transmission within the medical ward where the two patients were admitted. 
Authors concluded that NGS and WGS represent important tools for pathogen transmission 
investigation and a significant advance in clinical care providing pathogen detection with high 
resolution and reliability (243).
The same authors used this technology to rule out a nosocomial outbreak caused by respiratory virus, in 
children at high risk for pulmonary disease. Applying WGS and phylogenetic analysis, they excluded 
the possibility of a single source-transmission with a turnaround time of 24 hour (244).
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Phylogenetic analysis applied to WGS revealed to be essential to discriminate nosocomial outbreak 
strains from other strains isolated in the same setting but not related to the outbreak event, as recently 
demonstrated by Zhu et al. during an epidemiological investigation performed on respiratory syncytial 
virus-B strains circulating within a Unit of hematology and stem cell transplant. Authors compared the 
routine sequencing of glycoprotein (G) gene to the WGS and concluded that phylogenetic analysis 
applied to single gene sequence was not able to identify the cluster outbreak and that at this aim WGS 
was essential (245). 
Recently phylogenetic analysis was used to investigate the measles outbreak of nosocomial origin 
occurred in Milan, Italy between March-August 2017. This study by phylogenetic inference 
demonstrated the occurrence of three nosocomial clusters within an emergency department initially 
notified as unrelated cases, suggesting the importance of measles vaccination especially for the 
healthcare workers (246).
The importance of pyogenesis and phylodinamic applied to WGS has been further highlighted in case of 
viral nosocomial infection occurring in immunocompromised patients, such as Norovirus infection 
causing gastroenteritis worldwide affecting pediatric or immunosuppressed populations. Brown et al. in 
2018 by phylogenetic analysis of norovirus WGS showed that the nosocomial setting is characterized by 
multiple strains introduction and evidenced how this type of analysis is superior to the classic 
epidemiological investigation for infection control and prevention and should be routinely introduced in 
the hospital setting (247).
Conclusion
Epidemiology has been and still today is the first way to study viral infection and to face an epidemic 
event to reach a huge number of information to use in clinic and therapy. In these last years, the question 
that spring is “May phylogenetic analysis support and or complement an epidemiological 
investigation?” To answer this question is more complex as appear (Figure 6). Phylogeny and 
phylodinamic can give an immediate and important support studying the epidemiologic events not by 
the human point of view but by the microorganism point of view. Data on sequences isolated by the 
microorganism implied in the epidemic or pandemic events can give information on the origin and the 
spread of the event so as can track the geographical path of diffusion. In terms of nosocomial infection, 
can give important information on the source of the infection pinpointing the exact way of diffusion. On 
the other hand, classical epidemiology has focused on research of the risk factors related to behavioral 
patterns. When classical epidemiology is integrated by the phylogenetic and phylodinamics approaches 
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goes into a single analytical framework, called evolutionary epidemiology. This review and the 
examples discussed within showed the necessity to enrich the classical surveillance by the molecular 
phylogenetic analysis to better understand the emergence and spread of global infectious diseases in 
terms of regional epidemic so as in nosocomial outbreak. Despite research in the field of infectious 
disease phylodinamics is growing up, there is a need to apply molecular phylogenetic and evolutionary 
methods in areas out of infectious diseases, as well as translational genomics, and personalized 
medicine. The huge availability of genetic and clinical data give to the researchers a great opportunity to 
apply this molecular approach to studies of tumors and chronic infections, try to better understand the 
mechanism to the basis of complex transmission dynamics among tissues and cells. Phylogenetic studies 
can also give a great hand in vaccine studies and in antibiotic and antiviral resistant the last great battle 
in these times.
The major improvements from phylogenetic and phylodinamic analysis application in the field of viral 
infectious disease are represented by the possibility to enrich the classical epidemiology with genetic 
information thus widening the knowledge on viral epidemic and pathogen transmission.   
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Figure legends
Fig. 1. Percentage of papers published per year from 2010 to 2019 found by typing epidemiology, 
phylogeny and epidemiology plus phylogeny 
Fig. 2. Hippocrates, the father of epidemiology (panel A) and Charles Darwin, the father of phylogeny 
(panel B)
Fig. 3 The hypothetical cycle of the bioinformatics in molecular evolution. 
Fig. 4 Example of phylogenetic and phylodinamic approaches
Fig. 5 Mathematical evolutionary modeling applied on protein sequence (A) and structure analysis to 
make a prevision on the effect of selective pressure (B).
Fig. 6 The basis of molecular epidemiology 
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Fig. 1 Percentage of papers published per year from 2010 to 2019 found by typing epdiemiology, phylogeny 
and epidemiology plus phylogeny 
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Fig. 2 Hippocrates, the father of epidemiology (panel A) and Charles Darwin, the father of phylogeny (panel 
B). 
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Fig. 3 The hypothetical cycle of the bioinformatics in molecular evolution. 
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Fig. 4 Example of phylogenetic and phylodinamic approaches 
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Fig. 5 Mathematical evolutionary modeling applied on protein sequence (A) and structure analysis to make a 
prevision on the effect of selective pressure (B). 
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Fig. 6 The basis of molecular epidemiology 
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